Imaging Study of Anatomical Variations of the Superficial Temporal Artery (EVATSI)
Launched by UNIVERSITY HOSPITAL, BREST · Nov 24, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the EVATSI Clinical Trial**
The EVATSI study is looking at the superficial temporal artery, which is an important blood vessel located in the head. The goal of this research is to better understand the different shapes and sizes of this artery, which can help doctors perform medical procedures more effectively. By learning more about how this artery varies from person to person, the study aims to improve surgical and medical practices related to it.
If you are between the ages of 65 and 74 and are interested in participating, you may be eligible for this trial as long as you are willing to join and can undergo the necessary examinations. This study is currently recruiting participants of all genders. If you decide to join, you can expect to undergo some imaging tests that will help researchers learn more about the anatomy of the superficial temporal artery. Your participation could provide valuable insights that benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No opposition expressed
- • Examination analyzable
- Exclusion Criteria:
- • Refusal to participate
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported